135589-33-2

Upstream product

• 135589-32-1 2,4,6-trideoxy-2,4-di-C-methyl-carbethoxymethylidene-3-O-(p-methoxybenzyl)-5-O-(tert-butyldimethylsilyl)-D-galactose 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 3720-33-0 methyl-α,β-2,4,6-trideoxy-2,4-di-C-methyl-D-galactopyranoside 
• 135589-24-1 allyl-α,β-2,4,6-trideoxy-2,4-di-C-methyl-3-hydroxy-D-galactopyranoside 
• 81076-93-9 (3R,4S,5S,6R)-4-Benzyloxy-2-methoxy-3,5,6-trimethyl-tetrahydro-pyran 
• 135589-27-4 2,4,6-trideoxy-2,4-di-C-methyl-3-O-(p-methoxybenzyl)-D-dulcite 
• 135589-26-3 2,4,6-trideoxy-2,4-di-C-methyl-3-O-p-methoxybenzyl-α,β-D-galactopyranose 
• 135589-25-2 allyl-α,β-2,4,6-trideoxy-2,4-di-C-methyl-3-O-p-methoxybenzyl-D-galactopyranoside 
• 135589-30-9 2,4,6-trideoxy-2,4-di-C-methyl-3-O-(p-methoxybenzyl)-5-O-(tert-butyldimethylsilyl)-D-dulcite 
• 135589-31-0 2,4,6-trideoxy-2,4-di-C-methyl-3-O-(p-methoxybenzyl)-5-O-(tert-butyldimethylsilyl)-D-galactose 
• 135589-28-5 2,4,6-trideoxy-2,4-di-C-methyl-3-O-(p-methoxybenzyl)-1-O-benzoyl-D-dulcite 
• 135589-29-6 2,4,6-trideoxy-2,4-di-C-methyl-1-O-benzoyl-3-O-(p-methoxybenzyl)-5-O-(tert-butyldimethylsilyl)-D-dulcite 

Downstream Products

• 137894-17-8 (4S,5S,6R,7R,8R)-8-(tert-Butyl-dimethyl-silanyloxy)-6-(4-methoxy-benzyloxy)-2,5,7-trimethyl-non-2-en-4-ol 
• 137818-44-1 3,5,7-trideoxy-3,5-di-C-methyl-4-O-(p-methoxybenzyl)-6-O-(tert-butyldimethylsilyl)-1-isopropylidene-L-glucose 
• 135589-34-3 4,6,8-trideoxy-4,6-di-C-methyl-5-O-(p-methoxybenzyl)-7-O-(tert-butyldimethylsilyl)-D-threo-L-galactooctanol 
• 135589-31-0 2,4,6-trideoxy-2,4-di-C-methyl-3-O-(p-methoxybenzyl)-5-O-(tert-butyldimethylsilyl)-D-galactose 

Relevant academic research and scientific papers

SYNTHESIS OF MACROLIDE ANTIBIOTICS. 22. SYNTHESIS OF THE C8-C13 FRAGMENT OF OLEANDONOLIDE

The stereospecific synthesis of the C8-C13 fragment of oleandonolide was caried out in 15 steps with an overall yield of 4.48percent.